Serum Trypsinogen Activation Peptide in the Assessment of the Diagnosis and Severity of Acute Pancreatic Damage : A Pilot Study Using a New Determination Technique
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-11-01
著者
-
Morselli-labate A.
Department Of Internal Medicine S. Orsola-malpighi Hospital
-
Pezzilli R.
Department Of Internal Medicine S. Orsola-malpighi Hospital
-
Moneta D.
Department Of Toxicology Pharmacia Italia S. P. A. Pfizer Inc. Group
-
VENTURI M.
Department of Toxicology, Pharmacia Italia S. p. A., Pfizer Inc. Group
-
CECILIATO R.
Department of Internal Medicine, S. Orsola-Malpighi Hospital
-
LAMPARELLI M.
Department of Toxicology, Pharmacia Italia S. p. A., Pfizer Inc. Group
-
ROSSI A.
Department of Toxicology, Pharmacia Italia S. p. A., Pfizer Inc. Group
-
PISCITELLI L.
Department of Internal Medicine, S. Orsola-Malpighi Hospital
-
CORINALDESI R.
Department of Internal Medicine, S. Orsola-Malpighi Hospital
-
Piscitelli L.
Department Of Internal Medicine S. Orsola-malpighi Hospital
-
Rossi A.
Department Of Toxicology Pharmacia Italia S. P. A. Pfizer Inc. Group
-
Ceciliato R.
Department Of Internal Medicine S. Orsola-malpighi Hospital
-
Venturi M.
Department Of Toxicology Pharmacia Italia S. P. A. Pfizer Inc. Group
-
Corinaldesi R.
Department Of Internal Medicine S. Orsola-malpighi Hospital
-
Lamparelli M.
Department Of Toxicology Pharmacia Italia S. P. A. Pfizer Inc. Group
関連論文
- Plastic Changes in Neuropeptide Y Receptor Subtypes in Experimental Models of Limbic Seizures
- Serum Trypsinogen Activation Peptide in the Assessment of the Diagnosis and Severity of Acute Pancreatic Damage : A Pilot Study Using a New Determination Technique